one which precisely counteracts A TOT dilution. There is strong experimental evidence, both in vitro 26 and in vivo 11, 28 , that the fluid SID required is 24 mEq/l. The current investigation is a clinical validation of the above concepts, using cardiopulmonary bypass as a reproducible haemodilution model. The hypothesis tested was that acute normovolaemic haemodilution with a crystalloid SID of 24 mEq/l maintains normal metabolic acid-base balance better than a commercial 'balanced' alternative. We analysed acidbase changes after priming the circuit with either of two crystalloids, one being a saline preparation balanced by substituting 24 mEq/l of Cl -with HCO 3 -(SID=24 mEq/l), the other a commercial 'balanced' electrolyte solution in common use in Australia.
MATERIALS AND METHODS
The protocol was approved by the Human Research Ethics Committee of the Princess Alexandra Hospital. Written informed consent was obtained from 20 patients scheduled for elective cardiac surgery on the operating list of one surgeon. Patients with established acid-base disturbances or a predisposition to develop them, were excluded. Specific exclusion criteria were thus an abnormal preoperative venous plasma ] (<22 mEq/l or >27 mEq/l), hypercarbic respiratory failure, a plasma [creatinine] >120 µmol/l, diabetes mellitus and chronic liver disease.
On arrival in the anaesthesia induction room, patients were allocated to one of two groups, using computerised random number generation and sealed envelopes. One group received 2 l of Plasma-Lyte 148 (Baxter Healthcare, Toongabbie, NSW) as the circuit prime, the other the same volume of trial bicarbonate-balanced fluid. Aside from the wholebody perfusionist (gP, an investigator), all clinical and laboratory staff and all patients remained blinded to the fluid allocation.
Bicarbonate-balanced fluid was made up in the pump immediately prior to priming the circuit by sequential addition of 0.9% saline 1130 ml, 0.45% saline 822 ml (Baxter Healthcare, Toongabbie, NSW) and 8.4% sodium bicarbonate 48 ml (Astra Pharmaceuticals, Sydney, NSW). Compositions of bicarbonate-balanced fluid and Plasma-Lyte 148, along with the cardioplegia solution employed, are set out in Table 1 .
The bypass circuit incorporated a membrane oxygenator (Dideco Avante, Cellplex, Sorin, Mirondola, Italy) and heart-lung machine (Jostra HL 20, Maquet Critical Care AB, Solna, Sweden). Pump rate was set at 2.4 l/minute/m 2 and temperature ranged from 32 to 35°C.
During hypothermia, the alpha-stat strategy was used to control pH and P a CO 2 [30] [31] [32] SIg=SIDa-SIDe
Data analysis
The primary endpoint was SBE at time T2. Sample sizes of 10 subjects in each limb were chosen to detect a 1.5 mEq/l group mean difference with 80% power.
Secondary endpoints were the strong ion gap and apparent SID at T2 and T3. group differences for continuous outcome variables were compared after adjustment for baseline values at T1, using an analysis of covariance regression model 33 . Bypass time, clamp time, volume of cardioplegia and acuity scores were compared using the Wilcoxon 2-sample test. Statistical analysis was performed using SAS version 9.1 for Windows (SAS Institute, Carey, NC, USA). P values <0.05 were considered significant.
RESULTS
Patient details, type of surgery and bypass data are summarised in Tables 2 and 3 . SBE and strong ion gap values at the three time points are illustrated in Figures 1 and 2 . Acid-base, electrolyte and haemoglobin data are summarised in Tables 4 and 5 .
Of the 20 patients recruited, three were found to have missing laboratory data elements. As a result, nine patients in each limb were suitable for study of the primary endpoint, whereas for the secondary endpoints there were nine patients in the bicarbonatebalanced group and eight in the Plasma-Lyte 148 group (Table 2) . No blood products or cell saver blood were administered. Haemofiltration was not employed and additional alkalinising agents such as sodium bicarbonate and tris-hydroxymethyl aminomethane were not used.
There were no significant differences between groups in EuroSCORE or Parsonnet indices 34 , bypass times, clamp times or volumes of administered cardioplegia (Table 3 ). Additional Plasma-Lyte 148 boluses did not exceed 500 ml in any patient. All were discharged from the cardiac postoperative unit within 24 hours and all left the hospital alive.
SBE values at T1 confirmed normal baseline metabolic acid-base status in both groups and baseline strong ion gap values were also similar ( Table  4 , Figures 1 and 2 ). In the bicarbonate-balanced fluid group at T2 and T3, mean SBE and strong ion gap changed very little from T1 values. By contrast, mean SBE at T2 in the Plasma-Lyte 148 group was approximately 3 mEq/l less than T1 values, while the mean strong ion gap had increased by more than 10 mEq/l. Estimated group differences at T2 for SBE and strong ion gap after adjustment for baseline levels were 3.6 mEq/l (95% confidence interval [CI] 2.1 to 5.1 mEq/l, P=0.0001) and -10.4 mEq/l (95% CI -11.8 to -9.1 mEq/l, P <0.0001) respectively. By T3, SBE baseline adjusted differences had resolved, with both means close to zero. However although the mean strong ion gap in the PlasmaLyte 148 group had decreased to just over half the corresponding T2 value, it still significantly exceeded that of the bicarbonate-balanced fluid group. The estimated group strong ion gap difference at T3 was -3.1 mEq/l (95% CI -6.0 to -0.2 mEq/l, P=0.039).
SBE (mEq/l)
There were slight but significant group differences at T2 in mean haemoglobin concentrations (Table 5 ). There were also significant group differences in apparent SID at T2 and T3. Several individual electrolyte concentrations also differed between groups at T2 and T3, most notably the appearance of hyperchloraemia in the bicarbonate-balanced group at both time points. There were marked dilutional albumin and phosphate reductions on bypass, but they were similar in both groups. 
DISCUSSION
Our main finding was that, after priming with a crystalloid balanced on physical chemical principles using bicarbonate (SID 24 mEq/l), metabolic acidbase status was normal on commencement of cardiopulmonary bypass and again prior to separation. To our knowledge this is the first clinical confirmation that a crystalloid SID of 24 mEq/l delivers balanced haemodilution.
We used SBE as a global index of extracellular metabolic acid-base status 35, 36 and chose the strong ion gap in preference to the anion gap as a sensitive marker of plasma unmeasured ions in hypoalbuminaemia [30] [31] [32] . With the bicarbonate-balanced fluid, both SBE and the strong ion gap remained virtually unchanged at all three time points. From the Stewart perspective, a crystalloid SID of 24 mEq/l reduced extracellular SID by the precise amount required to offset the simultaneous dilution of extracellular A TOT . Plasma albumin, the main contributor to extracellular A TOT , decreased on bypass by over 10 g/l (Table 5) , whereas the apparent plasma SID reduction with bicarbonate-balanced prime was approximately 5 mEq/l (Table 4) . In other words, during crystalloid haemodilution a sizeable A TOT reduction can be offset by a modest decrement in extracellular SID.
By contrast, priming with Plasma-Lyte 148 initiated a complex sequence. An increase in the mean strong ion gap of >10 mEq/l at bypass initiation (T2) signalled a surge of unmeasured anions. However, the corresponding 3 mEq/l fall in SBE was less than half this increase. Our interpretation is that Plasma-Lyte 148 caused an immediate gluconate and/or acetate metabolic acidosis, partly concealed by a simultaneous metabolic alkalosis. Both abnormalities accord with the electrolyte profile of this crystalloid, which contains gluconate and acetate at a total concentration of 50 mEq/l (Table 1) , but which also has a SID of 50 mEq/l once these anions are completely eliminated. Thus a small overall shift in the direction of metabolic acidosis at T2 was the net result of two much larger competing acid-base disturbances.
At T3, prior to separation, the situation had evolved further in the Plasma-Lyte 148 group. Although the mean SBE was now normal, no longer differing from that of the bicarbonatebalanced group, the mean strong ion gap had only partially returned to baseline. In other words, unmeasured anions were still present but at reduced concentration. Their associated metabolic acidosis was now exactly offset by the metabolic alkalosis. In fact after T2 both groups had received extra increments of acetate and gluconate from the cardioplegia solution as well as Plasma-Lyte 148 boluses, but without apparent effect on T3 strong ion gap values in the bicarbonate-balanced fluid group.
It is noteworthy that Liskaser and colleagues also detected surges of unmeasured anions during bypass on Plasma-Lyte 148 prime 2 . However, neither their study nor the current report sheds light on individual concentrations of acetate versus gluconate at any time point. Acetate metabolism is rapid, 300 mEq/h in health 37 , with turnover presumably reduced during cardiopulmonary bypass. gluconate accumulates in situations where acetate does not 38 . During bypass on Plasma-Lyte 148 prime, gluconate concentrations may therefore be higher and more prolonged.
A question worth considering is whether protracted surges of exogenous organic anions are benign events during cardiopulmonary bypass. The absence of reported adverse effects from gluconate in non-bypass scenarios is reassuring. The same cannot be said of acetate [39] [40] [41] , which is unsuitable for inclusion in haemodialysis fluid 42 even at supplementary concentrations. Any specific impact of anionic surges would be challenging to detect when superimposed on the metabolic and host defence responses to surgery [43] [44] [45] [46] [47] [48] , hypothermia 49 and non-pulsatile blood flow 50 . Bicarbonate-balanced crystalloids such as the trial fluid avoid exogenous anions. On the other hand, hyperchloraemia is a predictable outcome, as demonstrated by the current data, simply because there must be a reduction in SID to match the diluted A TOT . The alternative is to manipulate SID by sodium reduction rather than chloride elevation, using hypotonic fluids. In our view, hyponatraemia is the less desirable option.
However, in theory a chloride increase may also have unwanted effects. Severe experimental hyperchloraemic acidosis is associated with reduced renal blood flow and glomerular filtration rate, iNOS activation, acute lung injury and intestinal dysfunction [14] [15] [16] [17] This study has drawbacks. groups were small and imperfectly matched, despite similar EuroSCORE and Parsonnet indices. The study was not fully blinded and there was some data loss. Cardioplegia solution and extra Plasma-Lyte 148 boluses were administered to both groups after T2, potentially contaminating T3 endpoints. Acetate and gluconate concentrations were not directly measured. Ionised magnesium measurements were unavailable. We preferred to accept small, relatively uniform reductions in apparent SID and strong ion gap values rather than estimate ionised magnesium from total concentrations.
While acknowledging these limitations, conclusions can be drawn. The most definite is confirmation that a crystalloid with a SID of 24 mEq/l is balanced when used as a circuit prime for cardiopulmonary bypass in patients with normal acid-base status, in keeping with experimental data. By comparison, Plasma-Lyte 148 is associated with a surge of unmeasured anions, some of which persist until late bypass. We speculate that these are gluconate and possibly acetate. Although there is no current evidence of harm, we raise the possibility that eliminating exogenous anionic surges with bicarbonate-balanced priming fluids might have advantages. While not studied in this paper, those most likely to benefit would have impaired liver function or pre-existing acid-base disturbances, similar to patients for whom bicarbonate-based continuous renal replacement therapy is indicated 53, 54 . Further work is warranted.
